Ahmed Bayomi
Family Medicine · Mason, OHNPI 1508071366
Payments from drug & device makers
Across 382 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amarin Pharma, Inc.$711
- Novo Nordisk$543
- Lilly USA, LLC$428
- Almatica Pharma LLC$372
- Pfizer$197
- plus $2K from 47 others
What the payments were for
- Food & beverage$5,550100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alinia$363
How this compares
$5,550 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $45,795 |
| EliquisApixaban | 33 | $43,964 |
| JanuviaSitagliptin Phosphate | 18 | $26,495 |
| LinzessLinaclotide | 20 | $24,361 |
| TrulicityDulaglutide | 13 | $23,678 |
| XareltoRivaroxaban | 16 | $18,074 |
| FarxigaDapagliflozin Propanediol | 11 | $12,399 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,742 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,695 |
| Famotidine | 62 | $1,961 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $1,711 |
| Omeprazole | 84 | $1,650 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $1,258 |
| Atorvastatin Calcium | 186 | $1,217 |
| Losartan Potassium | 64 | $959 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $543 | $45,79539 claims |
| PfizerEliquis | $197 | $43,96433 claims |
| MerckJanuvia | $31 | $26,49518 claims |
| AbbVieLinzess | $1,016 | $24,36120 claims |
| Lilly USA, LLCTrulicity | $428 | $23,67813 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $162 | $22,14126 claims |
| Johnson & JohnsonXarelto | $107 | $18,07416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Mason
- Albert WeisbrotMason$44K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.